On April 21, 2016, Judge Eldon E. Fallon, the federal judge supervising and overseeing the centralized litigation against Janssen, Johnson & Johnson and Bayer over Xarelto, issued an order scheduling the depositions of plaintiffs and defense witnesses. The court is overseeing the discovery necessary to develop several “bellwether” trials in order to evaluate the strength and weaknesses of the cases brought against the pharmaceutical giants and to determine the values of certain harms and injuries.
The depositions of the plaintiffs selected will take place in the federal courts near where the claimants live. The Court set the order of the depositions: plaintiff, prescribing doctor, treating doctor, and the sales representative who “detailed” the doctor, to be deposed where the depositions can fit in. The Court is determined to move these serious and complicated cases forward as expeditiously and efficiently as possible.
Contact Lieff Cabraser
Lieff Cabraser represents injured patients prescribed Xarelto in lawsuits charging Xarelto is a dangerous and defective drug because in some patients it triggers irreversible uncontrolled bleeding and other life-threatening complications. Xarelto (rivaroxaban) is sold in the U.S. by Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson (“J&J”). Our law firm has been recognized by U.S. News, Best Lawyers, and The National Law Journal as one of the top plaintiffs’ law firms in the nation. Please call us toll-free at 1 888-321-1510 or contact us by completing our online contact form.
Xarelto Drug and Injury Lawsuits Timeline
Read a timeline charting Xarelto’s release through reports of injuries and Xarelto lawsuits.